You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pexacerfont

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed, Placebo Trial run by the NIDA (Pexacerfont)

Terminated
  • Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed
  • Placebo
  • Pexacerfont
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 17, 2016

Alcohol-Related Disorders, Alcohol Dependence, Alcoholism Trial run by the NIAAA (Pexacerfont, Placebo)

Completed
Has Results
  • Alcohol-Related Disorders
  • +3 more
  • Pexacerfont
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2015

Generalized Anxiety Disorder Trial in United States (pexacerfont, escitalopram, )

Completed
  • Generalized Anxiety Disorder
  • pexacerfont
  • +2 more
  • Mesa, Arizona
  • +50 more
Sep 23, 2015

MDD Trial in United States (Pexacerfont, Escitalopram, Placebo)

Completed
  • Major Depressive Disorder
  • Pexacerfont
  • +2 more
  • Springdale, Arkansas
  • +44 more
Feb 27, 2010